Met Life Investment Management, LLC Fate Therapeutics Inc Transaction History

Met Life Investment Management, LLC

$16.6 Billion
Q2 2024

A detailed history of Met Life Investment Management, LLC transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Met Life Investment Management, LLC holds 59,989 shares of FATE stock, worth $172,168. This represents 0.0% of its overall portfolio holdings.

Number of Shares

59,989

Previous 38,329 56.51%

Holding current value

$172,168

Previous $281,000 30.25%

% of portfolio

0.0%

Previous 0.0%

40 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.26 - $7.08 $70,611 - $153,352	21,660 Added 56.51%	59,989 $196,000
Q1 2024 May 14, 2024	BUY	$3.54 - $8.35 $135,684 - $320,047	38,329 New	38,329 $281,000
Q2 2023 Apr 29, 2024	BUY	$4.76 - $6.59 $209,459 - $289,986	44,004 New	44,004 $209,000
Q1 2023 May 09, 2024	BUY	$4.24 - $11.12 $186,576 - $489,324	44,004 New	44,004 $251 Million
Q1 2022 May 10, 2024	BUY	$29.67 - $60.28 $1.31 Million - $2.65 Million	44,004 New	44,004 $1.71 Million
Q1 2022 Mar 22, 2023	BUY	$29.67 - $60.28 $463,979 - $942,658	15,638 Added 55.13%	44,004 $1.71 Million
Q1 2022 May 12, 2022	BUY	$29.67 - $60.28 $463,979 - $942,658	15,638 Added 55.13%	44,004 $1.71 Million
Q4 2021 Jun 21, 2023	SELL	$47.84 - $64.34 $748,121 - $1.01 Million	-15,638 Reduced 35.54%	28,366 $1.66 Million
Q3 2021 Jun 21, 2023	SELL	$59.27 - $95.73 $926,864 - $1.5 Million	-15,638 Reduced 35.54%	28,366 $1.68 Million
Q2 2021 Jun 21, 2023	SELL	$67.25 - $92.52 $1.05 Million - $1.45 Million	-15,638 Reduced 35.54%	28,366 $2.46 Million
Q1 2021 May 17, 2024	SELL	$72.16 - $117.4 $718,930 - $1.17 Million	-9,963 Reduced 25.99%	28,366 $2.34 Million
Q1 2021 Jun 26, 2023	SELL	$72.16 - $117.4 $1.13 Million - $1.84 Million	-15,638 Reduced 35.54%	28,366 $2.34 Billion
Q1 2021 Mar 22, 2023	SELL	$72.16 - $117.4 $15,153 - $24,654	-210 Reduced 0.73%	28,366 $2.34 Million
Q1 2021 May 14, 2021	SELL	$72.16 - $117.4 $15,153 - $24,654	-210 Reduced 0.73%	28,366 $2.34 Million
Q4 2020 May 24, 2024	SELL	$38.09 - $100.95 $64,105 - $169,898	-1,683 Reduced 5.56%	28,576 $2.6 Million
Q4 2020 Jun 22, 2023	SELL	$38.09 - $100.95 $587,652 - $1.56 Million	-15,428 Reduced 35.06%	28,576 $2.6 Million
Q4 2020 Mar 22, 2023	SELL	$38.09 - $100.95 $64,105 - $169,898	-1,683 Reduced 5.56%	28,576 $2.6 Million
Q4 2020 Feb 16, 2021	SELL	$38.09 - $100.95 $64,105 - $169,898	-1,683 Reduced 5.56%	28,576 $2.6 Million
Q3 2020 May 24, 2024	BUY	$30.41 - $40.5 $101,691 - $135,432	3,344 Added 12.42%	30,259 $1.21 Billion
Q3 2020 Jun 26, 2023	SELL	$30.41 - $40.5 $417,985 - $556,672	-13,745 Reduced 31.24%	30,259 $1.21 Million
Q3 2020 Mar 22, 2023	BUY	$30.41 - $40.5 $101,691 - $135,432	3,344 Added 12.42%	30,259 $1.21 Million
Q3 2020 Nov 13, 2020	BUY	$30.41 - $40.5 $101,691 - $135,432	3,344 Added 12.42%	30,259 $1.21 Million
Q2 2020 May 24, 2024	SELL	$20.21 - $35.23 $230,676 - $402,115	-11,414 Reduced 29.78%	26,915 $923 Million
Q2 2020 Jun 26, 2023	SELL	$20.21 - $35.23 $345,368 - $602,045	-17,089 Reduced 38.84%	26,915 $923,000
Q1 2020 Jul 12, 2023	SELL	$17.28 - $31.88 $295,297 - $544,797	-17,089 Reduced 38.84%	26,915 $597,000
Q4 2019 Jul 12, 2023	SELL	$13.39 - $20.73 $228,821 - $354,254	-17,089 Reduced 38.84%	26,915 $526,000
Q4 2019 Mar 22, 2023	BUY	$13.39 - $20.73 $48,940 - $75,768	3,655 Added 15.71%	26,915 $526,000
Q4 2019 Feb 14, 2020	BUY	$13.39 - $20.73 $48,940 - $75,768	3,655 Added 15.71%	26,915 $527,000
Q3 2019 Jul 12, 2023	SELL	$15.47 - $22.5 $320,909 - $466,740	-20,744 Reduced 47.14%	23,260 $361,000
Q3 2019 Mar 22, 2023	SELL	$15.47 - $22.5 $71,517 - $104,017	-4,623 Reduced 16.58%	23,260 $361,000
Q3 2019 Nov 14, 2019	SELL	$15.47 - $22.5 $71,517 - $104,017	-4,623 Reduced 16.58%	23,260 $361,000
Q2 2019 Jul 12, 2023	SELL	$15.61 - $20.44 $251,648 - $329,513	-16,121 Reduced 36.64%	27,883 $566,000
Q1 2019 Jul 13, 2023	SELL	$13.15 - $18.71 $211,991 - $301,623	-16,121 Reduced 36.64%	27,883 $489,000
Q4 2018 Jul 13, 2023	SELL	$11.48 - $16.98 $185,069 - $273,734	-16,121 Reduced 36.64%	27,883 $357,000
Q4 2018 Mar 22, 2023	SELL	$11.48 - $16.98 $91,093 - $134,736	-7,935 Reduced 22.15%	27,883 $357,000
Q4 2018 Feb 14, 2019	SELL	$11.48 - $16.98 $91,093 - $134,736	-7,935 Reduced 22.15%	27,883 $358,000
Q3 2018 Jul 13, 2023	SELL	$8.75 - $16.29 $183,102 - $340,884	-20,926 Reduced 47.55%	23,078 $375,000
Q3 2018 Mar 22, 2023	SELL	$8.75 - $16.29 $71,627 - $133,349	-8,186 Reduced 18.6%	35,818 $583,000
Q3 2018 Nov 14, 2018	BUY	$8.75 - $16.29 $111,475 - $207,534	12,740 Added 55.2%	35,818 $583,000
Q1 2018 May 15, 2018	BUY	$6.3 - $13.77 $145,391 - $317,784	23,078 New	23,078 $225,000

Others Institutions Holding FATE

# of Institutions

186

Shares Held

123M

Call Options Held

15K

Put Options Held

14K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $278M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Account

Met Life Investment Management, LLC Fate Therapeutics Inc Transaction History